Advanced Therapies Integrates
in partnership with
Enabling Strategic Debate and Collaboration Across the Advanced Therapies and Medicinal Products (ATMP) Industry
Innovation in pharmaceutical discovery and development is taking place at an astonishing pace. The genomics revolution and other advances have led to the emergence of highly effective, but extremely complex therapeutics, with cell and gene therapies, regenerative medicines and tissue therapies now transforming the prospects of patients and healthcare providers around the globe.
However there remain many strategic challenges to the effective development, deployment and utilisation of these ground-breaking medical technologies. Advanced Therapies Integrates will constitute a new forum, dedicated to bringing together the industry leaders to help drive and deliver the full potential ATMPs.
It will uniquely engage across the widest possible network: from pharma innovators, regulators, supply chain partners, equipment & technology providers, academia, industry associations, together with a wide array of government funding bodies and government supported pharma-focused initiatives.
Specific themes and objectives will cover deployment of the key innovations and debating challenges facing the industry including the regulatory and commercial barriers to effectively deploy such broad transformational changes.
Advanced Therapies Integrates will become the leading UK event that facilitates the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
Over 300 attendees live on the day
An in-person event with live streamed sessions.
1
Day
70+
Speakers
300+
Attendees
Core sectors covered
Cellular growth
How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.
Tech to translate
Discover the scientific and technological innovations to support your ATMP getting to market.
Making it
Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.
Key Speakers from 2022

Sharon Brownlow
Chief Business Officer
Cell & Gene Therapy Catapult

Tony Khoury
Executive Vice President
Project Farma

Jane Theaker
Chief Executive Officer
Kinomica

Joe Healey
Chief Executive Officer and Co-Founder
NanoSyrinx
Our valued sponsors

3 October 2023
Leonardo Royal Hotel London Tower Bridge
Sign up for life science integrates news
Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.